Associate Professor, Department of Medicine & Therapeutics, The Chinese University of Hong Kong
Research Focus
Chronic hepatitis B (CHB)
Metabolic dysfunction–associated steatotic liver disease (MASLD)
Methodology
Large-scale real-world healthcare data and advanced analytics for risk assessment and outcome prediction
Key Achievements
Established a long-term CHB cohort with HBsAg seroclearance
Principal Investigator of the international VCTE-Prognosis study
Education
BSc (Statistics, Hons), CUHK
MPhil (Risk Management Science), CUHK
PhD (Medical Sciences), CUHK
Expertise
Chronic viral hepatitis
MASLD
Risk modelling
Real-world clinical data
Awards
APASL Young Investigator Award 2018, 2022, 2023
Early Career Investigator Award in Clinical/Translational Science, AASLD 2020
Best Poster Presentation Award: Viral Hepatitis - Clinical, EASL 2024
Editorial & Service
Associate Editor, Journal of Hepatology
Statistical Editor, Clinical and Molecular Hepatology
Editorial Boards: CGH, AP&T, Hep Comm
AASLD HBV SIG - Communication Lead